Mengdan Liu Selected Research

ridaforolimus

7/2021	Ridaforolimus eluting stent for the treatment of Japanese patients with coronary disease: 1 year outcomes of the JNIR study.
1/2020	Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes From the BIONICS and NIREUS Trials.
1/2020	Outcomes of Patients With Coronary Arterial Bifurcation Narrowings Undergoing Provisional 1-Stent Treatment (from the BIONICS Trial).
12/2018	Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mengdan Liu Research Topics

Disease

6	Thrombosis (Thrombus) 01/2022 - 12/2018
5	Mitral Valve Insufficiency (Mitral Regurgitation) 10/2021 - 01/2020
5	Heart Failure 10/2021 - 01/2019
4	Myocardial Infarction 01/2022 - 12/2018
3	Death (Near-Death Experience) 01/2022 - 12/2018
3	Coronary Stenosis (Coronary Artery Stenosis) 01/2020 - 12/2018
3	Diabetes Mellitus 10/2019 - 12/2018
3	Hypertension (High Blood Pressure) 10/2019 - 01/2019
2	Hemorrhage 01/2022 - 02/2020
2	Chronic Renal Insufficiency 01/2020 - 01/2019
1	Rheumatoid Arthritis 07/2022
1	Osteoarthritis 07/2022
1	Retroperitoneal Fibrosis 03/2022
1	Hypersensitivity (Allergy) 01/2022
1	Drug Hypersensitivity (Drug Allergy) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Coronary Disease (Coronary Heart Disease) 07/2021
1	Arthritis (Polyarthritis) 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Necrosis 01/2020
1	Ischemia 01/2020
1	Anemia 01/2020
1	Leukemia 01/2020
1	Hyperlipidemias (Hyperlipidemia) 10/2019
1	Transient Ischemic Attack 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Stroke (Strokes) 01/2019
1	Atrial Fibrillation 01/2019
1	Thromboembolism 01/2019
1	Vascular Diseases (Vascular Disease) 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2017
1	Acute Coronary Syndrome 01/2017
1	Kaposi Sarcoma (Kaposi's Sarcoma) 12/2016
1	Infections 12/2016
1	Opportunistic Infections (Opportunistic Infection) 02/2014

Drug/Important Bio-Agent (IBA)

4	ridaforolimusIBA 07/2021 - 12/2018
2	ChromatinIBA 12/2016 - 12/2016
1	Semaphorins (Semaphorin)IBA 07/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	Poly AIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2021
1	mepolizumabIBA 01/2021
1	Glucagon (Glukagon)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	OvalbuminIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 02/2020
1	Glycoproteins (Glycoprotein)IBA 02/2020
1	bivalirudin (Angiomax)FDA Link 02/2020
1	zotarolimusIBA 01/2020
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2020
1	GTP Phosphohydrolases (GTPases)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Biotin (Vitamin H)FDA Link 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	ProteomeIBA 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020
1	C-Type Lectins (C-Type Lectin)IBA 01/2020
1	AnticoagulantsIBA 01/2019
1	APTIBA 01/2019
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2017
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2017

Therapy/Procedure

8	Stents 01/2022 - 12/2018
8	Therapeutics 10/2021 - 01/2019
1	Aftercare (After-Treatment) 03/2022
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2019
1	Transcatheter Aortic Valve Replacement 01/2019
1	Percutaneous Coronary Intervention 01/2019
1	Drug-Eluting Stents 12/2018
1	Art Therapy 02/2014